HCW Biologics (HCWB) Assets (2020 - 2025)
HCW Biologics' (HCWB) quarterly Assets came in at $24.5 million in Q4 2025, down 18.91% YoY from $30.2 million in Q4 2024, and down 3.64% on a QoQ basis from $25.4 million in Q3 2025.
HCW Biologics (HCWB) Assets (2020 - 2025) Analysis & Trends
HCW Biologics (HCWB) has 6 years of Assets data on file, last reported at $24.5 million in Q4 2025.
- Quarterly Assets fell 18.91% year-over-year to $24.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $24.5 million (down 18.91% YoY) and the FY2025 annual result came in at $24.5 million, down 18.91% from the prior year.
- Assets retreated to $24.5 million in Q4 2025, from $25.4 million in the prior quarter.
- In the past five years, Assets ranged from a high of $56.4 million in Q3 2021 to a low of $13.0 million in Q2 2021.
- A 5-year average of $36.1 million and a median of $30.4 million in 2024 frame the typical range for Assets.
- Annual changes were most pronounced in 2022 — Assets surged 263.75% — and 2023, when it tumbled 39.09%.
- Tracing HCWB's Assets over 5 years: stood at $53.5 million in 2021, then retreated by 12.53% to $46.8 million in 2022, then slumped by 39.09% to $28.5 million in 2023, then increased by 6.04% to $30.2 million in 2024, then fell by 18.91% to $24.5 million in 2025.
- The last three Assets figures came in at $24.5 million (Q4 2025), $25.4 million (Q3 2025), and $28.9 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | HCW Biologics | 2.86 Mn | 2.11 Mn | -93,887.00 | 26.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 24.52 Mn |
| Sep 30, 2025 | 25.45 Mn |
| Jun 30, 2025 | 28.91 Mn |
| Mar 31, 2025 | 26.29 Mn |
| Dec 31, 2024 | 30.24 Mn |
| Sep 30, 2024 | 26.56 Mn |
| Jun 30, 2024 | 26.82 Mn |
| Mar 31, 2024 | 30.43 Mn |
| Dec 31, 2023 | 28.51 Mn |
| Sep 30, 2023 | 35.62 Mn |
| Jun 30, 2023 | 39.48 Mn |
| Mar 31, 2023 | 43.53 Mn |
| Dec 31, 2022 | 46.81 Mn |
| Sep 30, 2022 | 51.35 Mn |
| Jun 30, 2022 | 47.41 Mn |
| Mar 31, 2022 | 50.96 Mn |
| Dec 31, 2021 | 53.51 Mn |
| Sep 30, 2021 | 56.41 Mn |
| Jun 30, 2021 | 13.03 Mn |
| Dec 31, 2020 | 15.40 Mn |